Abstract
Vinorelbine is an antimitotic anticancer agent and its main mechanism of action is related to the inhibition of microtubule dynamics leading to a mitotic arrest and cell death. Vinorelbine, as a microtubule destabilizing agent, stimulates microtubule depolymerization and mitotic spindle destruction at high concentration whereas at lower concentrations, it is able to block mitotic progression. Its main targets are tubulin and microtubules. Vinorelbine binds to β-tubulin subunits at Vinca-binding domain near the positive end of microtubules. The rapid and reversible binding by Vinorelbine to soluble tubulin induces a conformational change that increases the affinity of tubulin for itself which plays a key role in the kinetics of microtubule stabilization. This binding significantly reduces the rate of microtubule dynamics (lengthening and shortening) and increases the duration which microtubules spend in an attenuated state. This helps in proper assembly of the mitotic spindle and hence reduces the tension at the kinetochores of the chromosomes. Subsequently, chromosomes at the spindle poles are unable to progress to the spindle equator. The aim of this review is to examine the mechanism of the inhibition of cell proliferation by Vinorelbine and its efficacy in breast cancer patients in phase II studies.
Keywords: Antimitotic, cancer, vinorelbine, microtubule dynamics leading, tubulin, Vinca-binding, mitotic spindle, chromosomes, cytotoxic drugs, tissue homeostasis
Current Drug Targets
Title:Vinorelbine in Cancer Therapy
Volume: 13 Issue: 8
Author(s): Anna Capasso
Affiliation:
Keywords: Antimitotic, cancer, vinorelbine, microtubule dynamics leading, tubulin, Vinca-binding, mitotic spindle, chromosomes, cytotoxic drugs, tissue homeostasis
Abstract: Vinorelbine is an antimitotic anticancer agent and its main mechanism of action is related to the inhibition of microtubule dynamics leading to a mitotic arrest and cell death. Vinorelbine, as a microtubule destabilizing agent, stimulates microtubule depolymerization and mitotic spindle destruction at high concentration whereas at lower concentrations, it is able to block mitotic progression. Its main targets are tubulin and microtubules. Vinorelbine binds to β-tubulin subunits at Vinca-binding domain near the positive end of microtubules. The rapid and reversible binding by Vinorelbine to soluble tubulin induces a conformational change that increases the affinity of tubulin for itself which plays a key role in the kinetics of microtubule stabilization. This binding significantly reduces the rate of microtubule dynamics (lengthening and shortening) and increases the duration which microtubules spend in an attenuated state. This helps in proper assembly of the mitotic spindle and hence reduces the tension at the kinetochores of the chromosomes. Subsequently, chromosomes at the spindle poles are unable to progress to the spindle equator. The aim of this review is to examine the mechanism of the inhibition of cell proliferation by Vinorelbine and its efficacy in breast cancer patients in phase II studies.
Export Options
About this article
Cite this article as:
Capasso Anna, Vinorelbine in Cancer Therapy, Current Drug Targets 2012; 13 (8) . https://dx.doi.org/10.2174/138945012802009017
DOI https://dx.doi.org/10.2174/138945012802009017 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of Sulfotransferases by Xenobiotics
Current Drug Metabolism FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract
Current Drug Targets Low Concentration of Salinomycin Prevents Regrowth and Partially Depletes Human Glioma Cells Surviving High Concentrations of Alkylating Agents
Clinical Cancer Drugs Choice of Treatment with Antidepressants: Influencing Factors
Current Pharmaceutical Design Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy Retrometabolic Approach for Designing Personalized Anti- Cancer Drug Molecules for Controlling Breast Cancer Resulted by BRCA1 Mutations
Current Pharmacogenomics and Personalized Medicine Acridone-based Antitumor Agents: A Mini-review
Anti-Cancer Agents in Medicinal Chemistry Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line
Current Drug Delivery Design, Synthesis and Evaluation of Quinoline-based Small Molecule Inhibitor of STAT3
Letters in Drug Design & Discovery Biodistribution and Tumor Targeting of Indium and Iodine-labeled Shiga Toxin B-Subunit
Current Radiopharmaceuticals Formulated Squalene for Food Related Applications
Recent Patents on Food, Nutrition & Agriculture Adeno-Associated Virus-Mediated Gene Transfer in Hematopoietic Stem/Progenitor Cells as a Therapeutic Tool
Current Gene Therapy Dendritic Cell-Based Immunotherapy in Thyroid Malignancies
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Regulation of Tumor-Stromal Fibroblast Interactions: Implications in Anticancer Therapy
Current Medicinal Chemistry Azole Antimycotics - A Highway to New Drugs or a Dead End?
Current Medicinal Chemistry HGF Airway Over-expression Leads to Enhanced Pulmonary Vascularization without Induction of VEGF
Current Angiogenesis (Discontinued) pH-Sensitive Polymeric Micelles for Programmable Drug and Gene Delivery
Current Pharmaceutical Design A Review on Application of Particle Swarm Optimization in Bioinformatics
Current Bioinformatics Incretins Yesterday, Pleiotropic Gastrointestinal Hormones Today:Glucagon-Like Peptide-1 (GLP-1) and Glucose-ependent Insulinotropic Polypeptide (GIP)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery H+-myo-Inositol Transporter SLC2A13 as a Potential Marker for Cancer Stem Cells in an Oral Squamous Cell Carcinoma
Current Cancer Drug Targets